tiprankstipranks
Trending News
More News >
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market

Chimeric Therapeutics Ltd. (CHM) Ratios

Compare
10 Followers

Chimeric Therapeutics Ltd. Ratios

AU:CHM's free cash flow for Q2 2025 was AU$1.00. For the 2025 fiscal year, AU:CHM's free cash flow was decreased by AU$ and operating cash flow was AU$-0.48. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
0.64 0.64 2.35 3.08 <0.01
Quick Ratio
0.64 0.64 2.44 3.08 <0.01
Cash Ratio
0.37 0.37 2.04 3.05 <0.01
Solvency Ratio
-1.49 -1.49 -1.49 -1.25 1.40
Operating Cash Flow Ratio
-1.11 -1.11 -1.46 -1.20 -0.53
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 -1.00
Net Current Asset Value
AU$ -7.36MAU$ -7.36MAU$ 12.00MAU$ 11.29MAU$ -63.91K
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 340.07
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 -0.53
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 -1.14
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
3.95 3.95 1.36 1.45 >-0.01
Debt Service Coverage Ratio
-25.33 -25.33 -21.54 -2.34K 4.52
Interest Coverage Ratio
-38.10 -38.10 -21.59 -2.57K 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 <0.01
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
0.22 0.22 1.35 1.60 0.00
Profitability Margins
Gross Profit Margin
78.58%78.58%63.71%-31909.07%0.00%
EBIT Margin
-655.96%-655.96%-556.82%-570968.78%0.00%
EBITDA Margin
-533.01%-533.01%-520.53%-529090.33%0.00%
Operating Profit Margin
-654.44%-654.44%-527.98%-570968.78%0.00%
Pretax Profit Margin
-673.14%-673.14%-552.51%-571190.89%0.00%
Net Profit Margin
-575.20%-575.20%-558.77%-571190.89%0.00%
Continuous Operations Profit Margin
-575.20%-575.20%-607.48%-571190.89%0.00%
Net Income Per EBT
85.45%85.45%101.13%100.00%100.00%
EBT Per EBIT
102.86%102.86%104.65%100.04%100.00%
Return on Assets (ROA)
-115.83%-115.83%-41.93%-41.40%-64007.00%
Return on Equity (ROE)
-457.84%-457.84%-56.89%-60.14%100.15%
Return on Capital Employed (ROCE)
-383.80%-383.80%-53.44%-51.83%100.16%
Return on Invested Capital (ROIC)
-327.95%-327.95%-54.04%-50.94%0.65%
Return on Tangible Assets
-275.80%-275.80%-68.89%-66.64%0.46%
Earnings Yield
-157.42%-157.42%-44.16%-16.61%-0.07%
Efficiency Ratios
Receivables Turnover
1.23 1.23 0.98 0.11 0.00
Payables Turnover
0.13 0.13 0.20 0.42 0.00
Inventory Turnover
965.35K 965.35K -1.08 0.00 0.00
Fixed Asset Turnover
804.59 804.59 163.69 0.19 0.00
Asset Turnover
0.20 0.20 0.08 <0.01 0.00
Working Capital Turnover Ratio
1.32 1.32 0.19 <0.01 0.00
Cash Conversion Cycle
-2.50K -2.50K -1.78K 2.47K 0.00
Days of Sales Outstanding
295.77 295.77 370.67 3.34K 0.00
Days of Inventory Outstanding
<0.01 <0.01 -339.01 0.00 0.00
Days of Payables Outstanding
2.80K 2.80K 1.81K 878.33 0.00
Operating Cycle
295.77 295.77 31.66 3.34K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.04 -0.04 -0.04 -0.03 >-0.01
Free Cash Flow Per Share
-0.04 -0.04 -0.04 -0.04 >-0.01
CapEx Per Share
<0.01 <0.01 <0.01 0.02 0.00
Free Cash Flow to Operating Cash Flow
1.01 1.01 1.04 1.60 1.00
Dividend Paid and CapEx Coverage Ratio
-145.43 -145.43 -24.45 -1.67 0.00
Capital Expenditure Coverage Ratio
-145.43 -145.43 -24.45 -1.67 0.00
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 -1.00
Operating Cash Flow to Sales Ratio
-3.62 -3.62 -5.03 -3.34K 0.00
Free Cash Flow Yield
-99.79%-99.79%-41.34%-15.55%-0.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.64 -0.64 -2.26 -6.02 -1.52K
Price-to-Sales (P/S) Ratio
3.65 3.65 12.65 34.39K 0.00
Price-to-Book (P/B) Ratio
2.91 2.91 1.29 3.62 -1.53K
Price-to-Free Cash Flow (P/FCF) Ratio
-1.00 -1.00 -2.42 -6.43 -2.87K
Price-to-Operating Cash Flow Ratio
-1.01 -1.01 -2.52 -10.29 -2.87K
Price-to-Earnings Growth (PEG) Ratio
-0.01 -0.01 0.18 >-0.01 0.00
Price-to-Fair Value
2.91 2.91 1.29 3.62 -1.53K
Enterprise Value Multiple
-0.46 -0.46 -1.08 -4.90 0.00
Enterprise Value
11.09M 11.09M 14.73M 68.58M 97.54M
EV to EBITDA
-0.46 -0.46 -1.08 -4.90 0.00
EV to Sales
2.46 2.46 5.63 25.92K 0.00
EV to Free Cash Flow
-0.68 -0.68 -1.08 -4.85 -2.87K
EV to Operating Cash Flow
-0.68 -0.68 -1.12 -7.76 -2.87K
Tangible Book Value Per Share
-0.02 -0.02 0.03 0.03 -0.04
Shareholders’ Equity Per Share
0.01 0.01 0.07 0.08 >-0.01
Tax and Other Ratios
Effective Tax Rate
0.15 0.15 -0.01 0.02 2.40
Revenue Per Share
0.01 0.01 <0.01 <0.01 0.00
Net Income Per Share
-0.06 -0.06 -0.04 -0.05 >-0.01
Tax Burden
0.85 0.85 1.01 1.00 1.00
Interest Burden
1.03 1.03 0.99 1.00 0.42
Research & Development to Revenue
2.99 2.99 1.98 1.43K 0.00
SG&A to Revenue
2.65 2.65 3.34 2.20K 0.00
Stock-Based Compensation to Revenue
0.74 0.74 1.21 794.53 0.00
Income Quality
0.63 0.63 0.83 0.59 0.53
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis